Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of 12 weeks oral Pentalong on Exercise Capacity and Quality of Life
2009-015059-26Phase 2Completed
- Sponsor
- Allergan
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of isosorbide mononitrate in heart failure (HF) and secondary pulmonary hypertension, sponsored by Allergan. Primary endpoint: Pulmonary vascular resistance improvement. Started Jul 2010; status: completed.
02
Drugs
isosorbide mononitrate
03
Conditions
heart failure (HF)secondary pulmonary hypertension
Beyond the preview
Go deeper on 2009-015059-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015059-26.